Skip to content
MPMPMP202020

Drawing based on the label description. No photo yet.

MP 20 pill

Pill with imprint MP 20 is white, round, 8 mm and has been identified as Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-Ergocryptine Mesylate, and Dihydro-.beta.-Ergocryptine Mesylate 0.333 mg / 0.333 mg / 0.222 mg / 0.111 mg. It is supplied by Carilion Materials Management.

Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-Ergocryptine Mesylate, and Dihydro-.beta.-Ergocryptine Mesylate 0.333 mg / 0.333 mg / 0.222 mg / 0.111 mg

Imprint
MP 20
Strength
Dihydroergocornine Mesylate 0.333 mg / Dihydroergocristine Mesylate 0.333 mg / Dihydro-.alpha.-ergocryptine Mesylate 0.222 mg / Dihydro-.beta.-ergocryptine Mesylate 0.111 mg
Color
White
Shape
Round
Size
8 mm
Score
No score line
Form
Tablet
Manufacturer
Carilion Materials Management
NDC
68151-2780, 53489-281, 68151-2780-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-Ergocryptine Mesylate, and Dihydro-.beta.-Ergocryptine Mesylate pills and guides

What is Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-Ergocryptine Mesylate, and Dihydro-.beta.-Ergocryptine Mesylate used for?

Official uses from the US prescribing label

A proportion of individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity (i.e., cognitive and interpersonal skills, mood, self-care, apparent motivation) can experience some symptomatic relief upon treatment with ergoloid mesylates preparations. The identity of the specific trait(s) or condition(s), if any, which would usefully predict a response to ergoloid mesylates therapy is not known. It appears, however, that those individuals who do respond come from groups of patients who would be considered clinically to suffer from some ill-defined process related to aging or to have some underlying dementing condition (i.e., primary progressive dementia, Alzheimer's dementia, senile onset, multi-infarct dementia).

Before prescribing ergoloid mesylates, the physician should exclude the possibility that the patient's signs and symptoms arise from a potentially reversible and treatable condition. Particular care should be taken to exclude delirium and dementiform illness secondary to systemic disease, primary neurological disease, or primary disturbance of mood. Ergoloid mesylates preparations are not indicated in the treatment of acute or chronic psychosis, regardless of etiology (see CONTRAINDICATIONS ).

The decision to use ergoloid mesylates in the treatment of an individual with a symptomatic decline in mental capacity of unknown etiology should be continually reviewed since the presenting clinical picture may subsequently evolve sufficiently to allow a specific diagnosis and a specific alternative treatment. In addition, continued clinical evaluation is required to determine whether any initial benefit conferred by ergoloid mesylates therapy persists with time.

The efficacy of ergoloid mesylates was evaluated using a special rating scale known as the SCAG (Sandoz Clinical Assessment-Geriatric). The specific items on this scale on which modest but statistically significant changes were observed at the end of twelve weeks include: mental alertness, confusion, recent memory, orientation, emotional lability, self-care, depression, anxiety/fears, cooperation, sociability, appetite, dizziness, fatigue, bothersome(ness), and an overall impression of clinical status.

From the FDA-approved label on DailyMed (published Aug 05, 2016).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows MP 20. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, round, 8 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Ergoloid Mesylates.

Ingredients

Active: Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-Ergocryptine Mesylate, Dihydro-.beta.-Ergocryptine Mesylate

Inactive: Butylated Hydroxyanisole, Starch, Corn, Hydrogenated Cottonseed Oil, Lactose, Mannitol, Povidone K90, Stearic Acid, Talc

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.